166,234 research outputs found
Kaplan-Meier analysis of PFS.
No full text(A-D) Kaplan-Meier curves for PFS in EGFR mutant lung adenocarcinoma treated with EGFR-TKI. (E-H) Kaplan-Meier curves for PFS in EGFR mutant lung adenocarcinoma receiving EGFR-TKI as first line therapy.</p
Kaplan-Meier survival curves of all-cause mortality after CPI (including groups B, C, and D).
No full textKaplan-Meier survival curves of all-cause mortality after CPI (including groups B, C, and D).</p
Kaplan-Meier survival curves.
No full textKaplan-Meier survival curves for two consecutive acute (72 h) toxicity tests on D. magna in presence of breakdown NPs derived latex and silicone. Both graphs show a significant decrease in survival for D. magna in the breakdown latex samples.</p
Kaplan-Meier curve of survival by presence of NSVT.
No full textPanel A shows Kaplan-Meier survival curve in patients with or without NSVT. Panel B shows Kaplan-Meier curve of CV hospitalization-free survival in patients with or without NSVT. Panel C shows Kaplan-Meier curve of stroke-free survival in patients with or without NSVT. Panel D shows Kaplan-Meier curve of occurrence of new-onset HF free survival in patients with or without NSVT. CV indicates cardiovascular; CVA, cerebral vascular accident; HF, heart failure; NSVT, non-sustained ventricular tachycardia.</p
Kaplan-Meier survival analysis by baseline MLHFQ score tercile.
No full text(A) Kaplan-Meier survival analysis of the first quartile (score 0–28). (B) Kaplan-Meier survival analysis of the second quartile (score 28–39). (C) Kaplan-Meier survival analysis of the third quartile (score 39–48). (D) Kaplan-Meier survival analysis of the forth quartile (score >48).</p
Kaplan-Meier curves for different metastatic sites.
No full textThe Kaplan-Meier survival curves show the differences on survival probabilities among < 50 years, 50–59 years and ≥ 60 years patients with bone metastasis (A), brain metastasis (B), lung metastasis (C) and unknown metastasis (D).</p
Kaplan-Meier curves based on different factors.
No full textThe Kaplan-Meier survival curves show the differences on survival probabilities within high and low risk (A), among three age groups (B), among five histologic types (C) and whether received primary site surgery or not (D).</p
Kaplan-Meier analysis of overall survival between the E-Cohort and L-Cohort when stratified by BCLC stage 0~A (A), B (B), C (C), and D (D).
No full textKaplan-Meier analysis of overall survival between the E-Cohort and L-Cohort when stratified by BCLC stage 0~A (A), B (B), C (C), and D (D).</p
Kaplan- Meier analysis of CTCs levels and progression-free survival.
No full textKaplan-Meier curve showing progression-free survival estimates in mBC patients with - tumour and (D) mBC patients with luminal tumour.</p
- …
